11/12
08:00 am
lfmd
LifeMD to Participate in Three Investor Conferences During November
Low
Report
LifeMD to Participate in Three Investor Conferences During November
11/11
08:09 am
lfmd
LifeMD, Inc. (NASDAQ: LFMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
High
Report
LifeMD, Inc. (NASDAQ: LFMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
11/9
10:51 am
lfmd
LifeMD, Inc. 2024 Q3 - Results - Earnings Call Presentation [Seeking Alpha]
High
Report
LifeMD, Inc. 2024 Q3 - Results - Earnings Call Presentation [Seeking Alpha]
11/8
10:19 am
lfmd
LifeMD Inc (LFMD) Q3 2024 Earnings Call Highlights: Strong Telehealth Growth and Strategic ... [Yahoo! Finance]
Low
Report
LifeMD Inc (LFMD) Q3 2024 Earnings Call Highlights: Strong Telehealth Growth and Strategic ... [Yahoo! Finance]
11/7
04:18 pm
lfmd
LifeMD Reports Third Quarter 2024 Results [Yahoo! Finance]
Medium
Report
LifeMD Reports Third Quarter 2024 Results [Yahoo! Finance]
11/7
04:05 pm
lfmd
LifeMD Reports Third Quarter 2024 Results
High
Report
LifeMD Reports Third Quarter 2024 Results
11/6
08:00 am
lfmd
LifeMD® Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency
High
Report
LifeMD® Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency
11/6
07:57 am
lfmd
Earnings to Watch: LifeMD Inc (LFMD) Reports Q3 2024 Result [Yahoo! Finance]
High
Report
Earnings to Watch: LifeMD Inc (LFMD) Reports Q3 2024 Result [Yahoo! Finance]
10/24
08:00 am
lfmd
LifeMD® to Report Third Quarter 2024 Financial Results on November 7
Low
Report
LifeMD® to Report Third Quarter 2024 Financial Results on November 7
10/23
08:00 am
lfmd
LifeMD® Launches TestoRx, a New Rex MD® Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering
Medium
Report
LifeMD® Launches TestoRx, a New Rex MD® Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering
10/12
10:19 am
lfmd
LifeMD, Inc.'s (NASDAQ:LFMD) top owners are retail investors with 45% stake, while 38% is held by institutions [Yahoo! Finance]
Medium
Report
LifeMD, Inc.'s (NASDAQ:LFMD) top owners are retail investors with 45% stake, while 38% is held by institutions [Yahoo! Finance]
10/3
03:13 pm
lfmd
LifeMD, Inc. 8.875% CUM PFD A goes ex dividend tomorrow [Seeking Alpha]
Low
Report
LifeMD, Inc. 8.875% CUM PFD A goes ex dividend tomorrow [Seeking Alpha]
9/24
04:05 pm
lfmd
LifeMD® Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
Medium
Report
LifeMD® Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
9/20
11:09 am
lfmd
LifeMD, Inc. (NASDAQ: LFMD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $15.00 price target on the stock.
Medium
Report
LifeMD, Inc. (NASDAQ: LFMD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $15.00 price target on the stock.
9/19
08:00 am
lfmd
LifeMD Announces Major Enhancements to its Weight Management Program, Expanding Patient Access to Branded GLP-1 Therapies and Introducing New Treatment Options
Low
Report
LifeMD Announces Major Enhancements to its Weight Management Program, Expanding Patient Access to Branded GLP-1 Therapies and Introducing New Treatment Options
9/10
03:57 pm
lfmd
LifeMD: Selling WorkSimpli Could Be A Catalyst [Seeking Alpha]
Neutral
Report
LifeMD: Selling WorkSimpli Could Be A Catalyst [Seeking Alpha]
8/26
04:05 pm
lfmd
LifeMD to Participate in Three Investor Conferences During September
Medium
Report
LifeMD to Participate in Three Investor Conferences During September
8/23
09:07 am
lfmd
LifeMD, Inc. (NASDAQ: LFMD) is now covered by analysts at B. Riley. They set a "buy" rating and a $11.00 price target on the stock.
Low
Report
LifeMD, Inc. (NASDAQ: LFMD) is now covered by analysts at B. Riley. They set a "buy" rating and a $11.00 price target on the stock.